510(k) Report

510(k) · Cleared

Cleared

SwiftSight-Brain

K251483510(k) TraditionalCleared Sep 23, 2025132-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Airs Medical, Inc. · QIH Automated Radiological Image Processing Software

Cleared on Sep 23, 2025 as substantially equivalent to K242215 (Neurophet., Inc., 2024) after a 132-day review. Its family tree reaches back 4 generations to 2006.

Decided
Sep 23, 2025
Review
132 days
Class
Class II
Product code
QIH
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K061855 (2006). No later device cites it as a predicate yet.

  1. Root · 4 generations backK061855 NeuroquantCortechs Labs, Inc. · 2006
  2. 3 generations backK170981 NeuroQuantCortechs Labs, Inc. · 2017
  3. 2 generations backK220437 Neurophet AQUANeurophet., Inc. · 2023
  4. 1 generation backK242215 Neurophet AQUA (V3.1)Neurophet., Inc. · 2024
  5. This deviceK251483 SwiftSight-BrainAirs Medical, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K061855NeuroquantCortechs Labs, Inc.2006—
−3K170981NeuroQuantCortechs Labs, Inc.2017—
−2K220437Neurophet AQUANeurophet., Inc.2023—
−1K242215Neurophet AQUA (V3.1)Neurophet., Inc.2024—
0 (this device)K251483SwiftSight-BrainAirs Medical, Inc.2025—
FIG. 1 — Lineage of K251483, 2006–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QIH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QIH device

  1. #1 K213998 cvi42 Auto Imaging Software Applicationscore 23.5 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K242215Neurophet AQUA (V3.1)
Summary page 5
…- Classification name: System, image processing, radiological 4. Predicate device  Device trade name: Neurophet AQUA (V3.1)  510(k) number: K242215  Product specification - Regulation No. 21 CFR 892.2050 - Classification: Class II -…
Neurophet., Inc.2024—

Also cleared against K242215: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 5.7 years on median.
  • None of the 4 ancestors has a recall.
  • 1 other device also cites its predicate K242215.

How does its category compare?

All QIH devices

QIH Automated Radiological Image Processing Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · QIH

94in 2025

2019: 22020: 112021: 192022: 252023: 452024: 642025: 942026 (partial year): 78
2007high 94 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QIH

150in 2025

2020: 145 days median2021: 125 days median2022: 134 days median2023: 151 days median2024: 141 days median2025: 150 days median2026 (partial year): 130 days median
2007high 151 (2023) · low 125 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QIH

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QIH

4in 2025

2024: 22025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code QIH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20192—00
20201114500
20211912500
20222513400
20234515100
20246414102
20259415004
2026781301—

What is it indicated for?

This device is intended for automatic labelling, visualization and volumetric quantification of segmentable brain structures and lesions from a set of MR images. Volumetric data may be compared to reference percentile data.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K251483: SwiftSight-Brain.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K251483

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026